Tag | Content |
---|---|
Uniprot ID | P54841; Q3U3C8; Q3UPT9; |
Entrez ID | 16658 |
Genbank protein ID | EDL06288.1; AAH16434.1; BAE25306.1; AAH38256.1; BAE32860.1; BAE21161.1; AAD56221.1; AAA65689.1; |
Genbank nucleotide ID | NM_010658.3 |
Ensembl protein ID | ENSMUSP00000096728 |
Ensembl nucleotide ID | ENSMUSG00000074622 |
Gene name | Transcription factor MafB |
Gene symbol | Mafb |
Organism | Mus musculus |
NCBI taxa ID | 10090 |
Cleft type | |
Developmental stage | |
Data sources | Homology search |
Reference | |
Functional description | Acts as a transcriptional activator or repressor. Plays a pivotal role in regulating lineage-specific hematopoiesis by repressing ETS1-mediated transcription of erythroid-specific genes in myeloid cells. Required for monocytic, macrophage, osteoclast, podocyte and islet beta cell differentiation. Involved in renal tubule survival and F4/80 maturation. Activates the insulin and glucagon promoters. Together with PAX6, transactivates weakly the glucagon gene promoter through the G1 element. SUMO modification controls its transcriptional activity and ability to specify macrophage fate. Binds element G1 on the glucagon promoter. Involved either as an oncogene or as a tumor suppressor, depending on the cell context. Required for the transcriptional activation of HOXB3 in the rhombomere r5 in the hindbrain (PubMed:11823429). |
Sequence | MAAELSMGQE LPTSPLAMEY VNDFDLLKFD VKKEPLGRAE RPGRPCTRLQ PAGSVSSTPL 60 STPCSSVPSS PSFSPTEPKT HLEDLYWMAS NYQQMNPEAL NLTPEDAVEA LIGSHPVPQP 120 LQSFDGFRSA HHHHHHHHPH PHHGYPGAGV THDDLGQHAH PHHHHHHQAS PPPSSAASPA 180 QQLPTSHPGP GPHATAAATA AGGNGSVEDR FSDDQLVSMS VRELNRHLRG FTKDEVIRLK 240 QKRRTLKNRG YAQSCRYKRV QQKHHLENEK TQLIQQVEQL KQEVSRLARE RDAYKVKCEK 300 LANSGFREAG STSDSPSSPE FFL 323 |
Abbreviation :
CLO : cleft lip only. CPO : cleft palate only.
CLP : cleft lip and palate. CL/P : cleft lip with/without cleft palate.
For humans: CL/P, CLO, CPO, and CLP. For mice: CLO, CLP, and CPO.
Relation | Gene symbol | Entrez ID | UniProt ID | Cleft type | Developmental stage | Species | Evidence | Details |
---|---|---|---|---|---|---|---|---|
1:1 ortholog | MAFB | 532376 | F1N054 | Bos taurus | Prediction | More>> | ||
1:1 ortholog | MAFB | A0A452EFD6 | Capra hircus | Prediction | More>> | |||
1:1 ortholog | MAFB | 9935 | Q9Y5Q3 | CPO,CL/P | Homo sapiens | Publication | More>> | |
1:1 ortholog | Mafb | 16658 | P54841 | Mus musculus | Prediction | More>> | ||
1:1 ortholog | MAFB | 469941 | H2R8Y7 | Pan troglodytes | Prediction | More>> | ||
1:1 ortholog | A0A4X1TQX0 | Sus scrofa | Prediction | More>> | ||||
1:1 ortholog | Mafb | 54264 | P54842 | Rattus norvegicus | Prediction | More>> | ||
1:1 ortholog | mafb | Q98UK5 | Danio rerio | Prediction | More>> |
Gene symbol | Significant Variants/SNPS | Methods | PubMed ID |
---|---|---|---|
MAFB | rs6065259 | Mini-sequencing | 24972815 |
MAFB | rs13041247 | Mini-sequencing | 24972815 |
MAFB | rs13041247T>C | Genotyping and sequencing | 21834038 |
MAFB | rs17820943C>T | GWAS | 31609978 |
MAFB | rs6129653G>A | GWAS | 28232668 |
MAFB | rs13041247 | Genotyping and GWAS | 20436469 |
MAFB | rs17820943C>T (reduce risk) | Genotyping and GWAS | 32646788 |
MAFB | rs6072081A>G (reduce risk) | Genotyping and GWAS | 32646788 |
MAFB | rs13041247T>C (reduce risk) | Genotyping and GWAS | 32646788 |
MAFB | rs13041247T>C (reduce risk) | meta analysis | 31387249 |
MAFB | c.493C>G; p.His165Asn | GWAS | 25081408 |
MAFB | rs11696257 | Genotyping | 21567910 |
MAFB | rs13041247 | Genotyping | 21567910 |
MAFB | rs6016399 | Genotyping and GWAS | 27033726 |
MAFB | rs11698990 | Genotyping and GWAS | 27033726 |
MAFB | rs6102085 | Genotyping and GWAS | 27033726 |
MAFB | rs4810299 | Genotyping and GWAS | 27033726 |
MAFB | rs13041247 | GWAS | 20436469 |
MAFB | rs6072081 | GWAS | 20436469 |
MAFB | rs6065259 | GWAS | 20436469 |
MAFB | rs17820943 | GWAS | 20436469 |
MAFB | rs11696257 | GWAS | 20436469 |
MAFB | rs6102085 | GWAS | 20436469 |
GO ID | GO Term | Evidence |
---|---|---|
GO:0000978 | RNA polymerase II cis-regulatory region sequence-specific DNA binding | IMP |
GO:0000978 | RNA polymerase II cis-regulatory region sequence-specific DNA binding | IBA |
GO:0000981 | DNA-binding transcription factor activity, RNA polymerase II-specific | ISO |
GO:0001228 | DNA-binding transcription activator activity, RNA polymerase II-specific | IMP |
GO:0003677 | DNA binding | IDA |
GO:0003700 | DNA-binding transcription factor activity | IBA |
GO:0005515 | protein binding | IPI |
GO:0008134 | transcription factor binding | ISO |
GO:0042802 | identical protein binding | ISO |
GO:0043565 | sequence-specific DNA binding | IBA |
GO:0044877 | protein-containing complex binding | ISO |
GO:1990837 | sequence-specific double-stranded DNA binding | ISO |
GO ID | GO Term | Evidence |
---|---|---|
GO:0006355 | regulation of transcription, DNA-templated | ISO |
GO:0006357 | regulation of transcription by RNA polymerase II | IDA |
GO:0007379 | segment specification | IMP |
GO:0007585 | respiratory gaseous exchange by respiratory system | IMP |
GO:0021571 | rhombomere 5 development | IMP |
GO:0021572 | rhombomere 6 development | IMP |
GO:0021599 | abducens nerve formation | IMP |
GO:0033077 | T cell differentiation in thymus | IMP |
GO:0035284 | brain segmentation | IMP |
GO:0042472 | inner ear morphogenesis | IMP |
GO:0045647 | negative regulation of erythrocyte differentiation | ISO |
GO:0045671 | negative regulation of osteoclast differentiation | IDA |
GO:0045944 | positive regulation of transcription by RNA polymerase II | ISO |
GO:0045944 | positive regulation of transcription by RNA polymerase II | IMP |
GO:0045944 | positive regulation of transcription by RNA polymerase II | IDA |
GO:0048538 | thymus development | IMP |
GO ID | GO Term | Evidence |
---|---|---|
GO:0005634 | nucleus | ISO |
GO:0005634 | nucleus | IDA |
GO:0005634 | nucleus | IBA |
GO:0005654 | nucleoplasm | TAS |
GO:0005667 | transcription factor complex | IDA |
Reactome ID | Reactome Term | Evidence |
---|
PROSITE ID | PROSITE Term |
---|---|
PS50217 | BZIP |